Literature DB >> 26786388

Interventions to improve patient understanding of cancer clinical trial participation: a systematic review.

C Y Kao1,2, S Aranda2,3, M Krishnasamy2,4, B Hamilton2.   

Abstract

Patient misunderstanding of cancer clinical trial participation is identified as a critical issue and researchers have developed and tested a variety of interventions to improve patient understanding. This systematic review identified nine papers published between 2000 and 2013, to evaluate the effects of interventions to improve patient understanding of cancer clinical trial participation. Types of interventions included audio-visual information, revised written information and a communication training workshop. Interventions were conducted alone or in combination with other forms of information provision. The nine papers, all with methodological limitations, reported mixed effects on a small range of outcomes regarding improved patient understanding of cancer clinical trial participation. The methodological limitations included: (1) the intervention development process was poorly described; (2) only a small element of the communication process was addressed; (3) studies lacked evidence regarding what information is essential and critical to enable informed consent; (4) studies lacked reliable and valid outcome measures to show that patients are sufficiently informed to provide consent; and (5) the intervention development process lacked a theoretical framework. Future research needs to consider these factors when developing interventions to improve communication and patient understanding during the informed consent process.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cancer; clinical trial; communication; informed consent; understanding

Mesh:

Year:  2016        PMID: 26786388     DOI: 10.1111/ecc.12424

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  4 in total

1.  What advanced cancer patients with limited treatment options know about clinical research: a qualitative study.

Authors:  Sarah B Garrett; Christopher J Koenig; Laura Trupin; Fay J Hlubocky; Christopher K Daugherty; Anne Reinert; Pamela Munster; Daniel Dohan
Journal:  Support Care Cancer       Date:  2017-05-09       Impact factor: 3.603

2.  The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).

Authors:  Talia Golan; Michele Milella; Aliza Ackerstein; Ranaan Berger
Journal:  J Exp Clin Cancer Res       Date:  2017-12-28

Review 3.  The CORBEL matrix on informed consent in clinical studies: a multidisciplinary approach of Research Infrastructures Building Enduring Life-science Services.

Authors:  Cinzia Colombo; Michaela Th Mayrhofer; Christine Kubiak; Serena Battaglia; Mihaela Matei; Marialuisa Lavitrano; Sara Casati; Victoria Chico; Irene Schluender; Tamara Carapina; Paola Mosconi
Journal:  BMC Med Ethics       Date:  2021-07-17       Impact factor: 2.652

4.  Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.

Authors:  Henri-Corto Stoeklé; Marie-France Mamzer-Bruneel; Charles-Henry Frouart; Christophe Le Tourneau; Pierre Laurent-Puig; Guillaume Vogt; Christian Hervé
Journal:  Sci Eng Ethics       Date:  2017-03-09       Impact factor: 3.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.